681 related articles for article (PubMed ID: 1763238)
1. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
2. An integrated in vitro carcinogenicity test that distinguishes between genotoxic carcinogens, non-genotoxic carcinogens, and non-carcinogens.
Chapman KE; Shah UK; Fletcher JF; Johnson GE; Doak SH; Jenkins GJS
Mutagenesis; 2024 Mar; 39(2):69-77. PubMed ID: 38301659
[TBL] [Abstract][Full Text] [Related]
3. A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells.
Wilde EC; Chapman KE; Stannard LM; Seager AL; Brüsehafer K; Shah UK; Tonkin JA; Brown MR; Verma JR; Doherty AT; Johnson GE; Doak SH; Jenkins GJS
Arch Toxicol; 2018 Feb; 92(2):935-951. PubMed ID: 29110037
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review.
Chappell G; Pogribny IP; Guyton KZ; Rusyn I
Mutat Res Rev Mutat Res; 2016; 768():27-45. PubMed ID: 27234561
[TBL] [Abstract][Full Text] [Related]
5. Prediction of carcinogenic potential by a toxicogenomic approach using rat hepatoma cells.
Tsujimura K; Asamoto M; Suzuki S; Hokaiwado N; Ogawa K; Shirai T
Cancer Sci; 2006 Oct; 97(10):1002-10. PubMed ID: 16918996
[TBL] [Abstract][Full Text] [Related]
6. Global structure-activity relationship model for nonmutagenic carcinogens using virtual ligand-protein interactions as model descriptors.
Cunningham AR; Carrasquer CA; Qamar S; Maguire JM; Cunningham SL; Trent JO
Carcinogenesis; 2012 Oct; 33(10):1940-5. PubMed ID: 22678118
[TBL] [Abstract][Full Text] [Related]
7. The limits of two-year bioassay exposure regimens for identifying chemical carcinogens.
Huff J; Jacobson MF; Davis DL
Environ Health Perspect; 2008 Nov; 116(11):1439-42. PubMed ID: 19057693
[TBL] [Abstract][Full Text] [Related]
8. A weight of evidence evaluation of the mode of action of isoeugenol.
Brock WJ; Greene T; Van Landingham C; Gentry R
Regul Toxicol Pharmacol; 2024 Jun; 150():105642. PubMed ID: 38735521
[TBL] [Abstract][Full Text] [Related]
9. Intestinal carcinogenicity screening of environmental pollutants using organoid-based cell transformation assay.
Wang Z; Chen S; Guo Y; Zhang R; Zhang Q; Jiang X; Li M; Jiang Y; Ye L; Guo X; Li C; Zhang G; Li D; Chen L; Chen W
Arch Toxicol; 2024 Jun; 98(6):1937-1951. PubMed ID: 38563870
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency.
Snodin DJ; Trejo-Martin A; Ponting DJ; Smith GF; Czich A; Cross K; Custer L; Elloway J; Greene N; Kalgutkar AS; Stalford SA; Tennant RE; Vock E; Zalewski A; Ziegler V; Dobo KL
Chem Res Toxicol; 2024 Feb; 37(2):181-198. PubMed ID: 38316048
[TBL] [Abstract][Full Text] [Related]
11. Conflicting views on chemical carcinogenesis arising from the design and evaluation of rodent carcinogenicity studies.
Melnick RL; Thayer KA; Bucher JR
Environ Health Perspect; 2008 Jan; 116(1):130-5. PubMed ID: 18197312
[TBL] [Abstract][Full Text] [Related]
12. Pathologists' perspective on the study design, analysis, and interpretation of proliferative lesions in a lifetime rodent carcinogenicity bioassay of sucralose.
Elmore SA; Rehg JE; Schoeb TR; Everitt JI; Bolon B
Food Chem Toxicol; 2024 Jun; 188():114524. PubMed ID: 38428799
[TBL] [Abstract][Full Text] [Related]
13. Prioritizing of potential environmental exposure carcinogens beyond IARC group 1-2B based on weight of evidence (WoE) approach.
Zhang L; Li M; Zhang D; Yue W; Qian Z
Regul Toxicol Pharmacol; 2024 Jun; 150():105646. PubMed ID: 38777300
[TBL] [Abstract][Full Text] [Related]
14. A proposal to improve clarity and communication in the EU Classification process for chemicals for carcinogenicity and reproductive and developmental toxicity.
Doe JE
J Appl Toxicol; 2014 Oct; 34(10):1068-72. PubMed ID: 25059745
[TBL] [Abstract][Full Text] [Related]
15. Integrating publicly available information to screen potential candidates for chemical prioritization under the Toxic Substances Control Act: A proof of concept case study using genotoxicity and carcinogenicity.
Patlewicz G; Dean JL; Gibbons CF; Judson RS; Keshava N; Vegosen L; Martin TM; Pradeep P; Simha A; Warren SH; Gwinn MR; DeMarini DM
Comput Toxicol; 2021 Nov; 20():1-100185. PubMed ID: 35128218
[TBL] [Abstract][Full Text] [Related]
16. What is the meaning of 'A compound is carcinogenic'?
Schrenk D
Toxicol Rep; 2018; 5():504-511. PubMed ID: 29854622
[TBL] [Abstract][Full Text] [Related]
17. QSAR Models for Human Carcinogenicity: An Assessment Based on Oral and Inhalation Slope Factors.
Toma C; Manganaro A; Raitano G; Marzo M; Gadaleta D; Baderna D; Roncaglioni A; Kramer N; Benfenati E
Molecules; 2020 Dec; 26(1):. PubMed ID: 33383938
[TBL] [Abstract][Full Text] [Related]
18. A modular strategy for the testing and assessment of non-genotoxic carcinogens.
Louekari K; Jacobs MN
Arch Toxicol; 2024 May; ():. PubMed ID: 38811392
[TBL] [Abstract][Full Text] [Related]
19. (N-NITROSO) PROPAFENONE INDUCED ADVANCED NODULAR MELANOMA-FIRST REPORTED CASE IN THE WORLD LITERATURE: THE INEXTRICABLE LINKS BETWEEN THE PHOTOCARCINOGENESIS, DRUG RELATED NITROSOGENESIS AND PHARMACO-ONCOGENESIS.
Tchernev G
Georgian Med News; 2024 Feb; (347):34-37. PubMed ID: 38609110
[TBL] [Abstract][Full Text] [Related]
20. Moving forward in carcinogenicity assessment: Report of an EURL ECVAM/ESTIV workshop.
Corvi R; Madia F; Guyton KZ; Kasper P; Rudel R; Colacci A; Kleinjans J; Jennings P
Toxicol In Vitro; 2017 Dec; 45(Pt 3):278-286. PubMed ID: 28911985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
